IDXX
NasdaqIDEXX LABORATORIES INC /DE
Health Care, Health Care Equipment
$586.67
close 7 Aug 2026
-10.04%
52-week change
$46.27B
market cap
$518.55
$769.98
52-week range
Valuation
Market cap$46.27B
P/E (TTM / 5y avg)41.23x51.42x
Forward P/E (FY2026 / FY2027)39.66x35.15x
PEG (TTM / fwd)2.333.09
P/S (TTM)10.16x
P/B28.70x
EV/EBITDA (TTM)28.85x
FCF yield (TTM)2.71%
Cash flow & dividend
FCF (TTM)$1.25B
FCF per share (TTM)$15.90
FCF margin (TTM)27.55%
Dividend yield (indicated / 5y avg)——
Annualized dividend—
Payout ratio (EPS / FCF)——
Growth & quality
Revenue YoY, latest Q+9.66%
Diluted EPS YoY, latest Q+17.63%
Operating margin (TTM)32.03%
Net margin (TTM)25.03%
ROE (latest FY)65.99%
Net debt / EBITDA (TTM)0.16
Interest coverage (TTM)38.60
Price
-12.71%-2.69%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +9.72%10Y CAGR +10.39%
Diluted EPS
5Y CAGR +14.28%10Y CAGR +20.36%
FCF per share
5Y CAGR +15.90%10Y CAGR +24.30%
Operating cash flow
5Y CAGR +12.77%10Y CAGR +18.21%
Free cash flow
5Y CAGR +14.33%10Y CAGR +22.50%
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -1.38%10Y CAGR -1.60%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date2 Nov 2026bmo
EPS estimate$3.85
Revenue estimate$1.22B
Last reported
Date—
EPS——
Revenue——